- Report
- March 2025
- 262 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- December 2024
- 389 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 192 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 198 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- January 2025
- 194 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- January 2025
- 182 Pages
Global
From €4742EUR$4,995USD£4,000GBP
- Report
- January 2025
- 93 Pages
Europe
From €3275EUR$3,450USD£2,763GBP
- Report
- January 2025
- 88 Pages
North America
From €3275EUR$3,450USD£2,763GBP
- Report
- January 2025
- 73 Pages
Africa, Middle East
From €3275EUR$3,450USD£2,763GBP
- Report
- December 2024
- 88 Pages
Asia Pacific
From €3275EUR$3,450USD£2,763GBP
- Report
- July 2024
- 109 Pages
North America
From €3275EUR$3,450USD£2,763GBP
- Report
- July 2024
- 109 Pages
Africa, Middle East
From €3275EUR$3,450USD£2,763GBP
- Report
- July 2024
- 113 Pages
Europe
From €3275EUR$3,450USD£2,763GBP
- Report
- July 2024
- 113 Pages
Asia Pacific
From €3275EUR$3,450USD£2,763GBP
- Report
- May 2022
- 231 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- January 2024
- 213 Pages
Global
From €4414EUR$4,650USD£3,724GBP
- Report
- May 2022
- 109 Pages
Global
From €5221EUR$5,500USD£4,404GBP
- Report
- February 2024
- 202 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2022
- 194 Pages
Global
From €4747EUR$5,000USD£4,004GBP

The Human Vaccine market is a segment of the larger Vaccine industry, which focuses on the development and distribution of vaccines to protect humans from infectious diseases. Vaccines are typically administered through injections, although some may be administered orally or nasally. Vaccines are designed to stimulate the body's immune system to recognize and fight off a particular disease. Vaccines are typically developed through a combination of laboratory research, clinical trials, and regulatory approval.
The Human Vaccine market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market are focused on developing new vaccines, as well as improving existing vaccines. They are also involved in the production, distribution, and marketing of vaccines.
Some of the major companies in the Human Vaccine market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Johnson & Johnson, and Novartis. Show Less Read more